Name: UMIN ID:
Unique ID issued by UMIN | UMIN000011971 |
---|---|
Receipt number | R000013982 |
Scientific Title | Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicenter Stop Imatinib in Japan adult leukemia study group study |
Date of disclosure of the study information | 2013/11/01 |
Last modified on | 2017/10/09 15:20:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/10/06 19:48:54 | ||
2 | Update | 2013/11/12 00:36:16 | Date of protocol fixation Anticipated trial start date |
|
3 | Update | 2013/12/14 21:06:10 | Recruitment status Anticipated trial start date URL releasing protocol |
|
4 | Update | 2014/03/22 10:59:26 | Recruitment status |
|
5 | Update | 2014/08/01 10:38:08 | Recruitment status Last follow-up date |
|
6 | Update | 2014/10/27 22:52:30 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2016/04/06 13:21:21 | Name of primary person or sponsor Organization Category of Funding Organization |
|
8 | Update | 2017/10/09 15:20:31 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications |